Insider Transactions Reported by 24 Insiders of Cerevel Therapeutics Holdings, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 15 Mar 2025

Cerevel Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Abraham Ceesay President $1,228,358 06 Feb 2023
PFIZER INC Former 10% Owner $0 01 Aug 2024
BAIN CAPITAL INVESTORS LLC Director, 10%+ Owner $0 01 Aug 2024
Ronald C. Renaud Jr. President & CEO, Director $0 01 Aug 2024
PATRICK DEVAL L Director $0 01 Aug 2024
Paul D. Burgess Chief Business Development and Strategic Operations Officer $0 01 Aug 2024
Gabrielle Sulzberger Director $0 01 Aug 2024
Kathleen Tregoning Chief Corporate Affairs Officer $0 01 Aug 2024
Norbert G. Riedel Director $0 01 Aug 2024
PERCEPTIVE ADVISORS LLC Director $0 20 Feb 2024
Ruth Mckernan Director $0 01 Aug 2024
Ramiro Sanchez Chief Medical Officer $0 01 Aug 2024
N. Anthony Coles Director $0 01 Aug 2024
Marijn E. Dekkers Director $0 01 Aug 2024
Adam Koppel Director, 10%+ Owner $0 01 Aug 2024
Mark Bodenrader Senior Vice President, Finance and Chief Accounting Officer $0 01 Aug 2024
Susan Altschuller Chief Financial Officer $0 01 Aug 2024
Scott Akamine Chief Legal Officer $0 01 Aug 2024
Douglas E. Giordano Director $0 01 Aug 2024
Christopher R. Gordon Director, 10%+ Owner $0 01 Aug 2024
John Renger Chief Scientific Officer $0 01 Aug 2024
Kenneth DiPietro Chief Human Resources Officer $0 01 Aug 2024
PF Equity Holdings 1 B.V. 10%+ Owner 31 Mar 2022
Suneet Varma Director 14 Jun 2022

Recent Insider Transactions by Companies or Individuals for Cerevel Therapeutics Holdings, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.